Intra-arterial gemcitabine vs IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer. Nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with or without GVAX for locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results